Work

Plasma CD4 Count and Duration ARV as a Predictor of Virological Failure Amongst AIDS Patients

Year: 2021
Type: article
Study design: Observational Study
Abstract: Background: The 90-90-90 strategy to overcome the HIV/AIDS (Human Immunodeficiency Virus/AcquiredImmunodeficiency Syndrome) epidemic in the world still has challenges because 20% of people live withHIV/AIDS (PLWHA) received anti retroviral (ARVs) are at risk of virological failure. This study describesand analyzes the factors that influence the occurrence of virological failure in AIDS patients who have takenARVs.Method: A hospital based cross-sectional study and retrospective medical record review in Dr. SoetomoTeaching Hospital Surabaya from January 2017 until December 2018. Virological failure is plasma viralload greater than 1000 copies/ml.Result: According to data analysis for each variable, we used a CD4 (Cluster of Differentiation) cut-offof 134 cells/?l and ? 20.5 months for virological failure. There was a statistically significant relationshipbetween CD4 cell count 95% CI (1.33-11,281) p 0.010 and duration of ARV (1,396-11.78) 95% CI p 0.01.Summation of total score from both variables has a p value <0.001 which means the total score of the twovariables is significant as a predictor of virological failure. The total area of the ROC curve is 73.6% with asensitivity of 81.5% and specificity of 44.4%.Conclusion: The duration of ARV consumption and CD4 cell count have an effect and can be an initialevaluation of the occurrence of virological failure.
Language: English
Field: Medicine
Open Access status: bronze
OpenAlex ID: W3136692539
FWCI:
Cites: 7
Cited by: 1
Related to: 10